Xvivo Perfusion: Q3 expectations
Research Note
2019-10-23
05:50
Xvivo is scheduled to release the results for the quarter ended September 30, 2019, tomorrow before the stock market opens. Following the release, the company will host a telephone conference at 2:00 p.m. We expect to see continued strong growth, driven by increasing sales related to warm perfusion.
AN
Arvid Necander
Disclosures and disclaimers